Overview

A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent

Status:
Active, not recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The main objective is to assess the benefit-risk ratio of a risk-adapted strategy for treatment of extra cranial NSMGCT in children and adolescent.
Phase:
Phase 2
Details
Lead Sponsor:
Centre Leon Berard
Treatments:
Bleomycin
Cisplatin
Ifosfamide
Isophosphamide mustard
Vinblastine